Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

Details for Australian Patent Application No. 2007309727 (hide)

Owner Ordway Research Institute Albany College of Pharmacy Charitable Leadership Foundation

Inventors Davis, Paul J.; Mousa, Shaker A.; Davis, Faith B.

Agent Cullen & Co

Pub. Number AU-A-2007309727

PCT Pub. Number WO2008/051291

Priority 60/791,235 11.04.06 US; 60/831,740 17.07.06 US; 60/856,450 02.11.06 US

Filing date 11 April 2007

Wipo publication date 2 May 2008

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

20 November 2008 PCT application entered the National Phase

  PCT publication WO2008/051291 Priority application(s): WO2008/051291

13 May 2010 Alteration of Name

  The name of the applicant has been altered to Ordway Research Institute, Inc.; Albany College of Pharmacy and Health Sciences

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309735-Heater and method of treating a subsurface formation therewith

2007309726-Steroid responsive nucleic acid expression and prediction of disease activity